| CAS: | 185669-79-8 | |
| 分子式: | C19H19NO | |
| 分子量: | 277.36 | |
| 沸点: | 436.5±25.0°C at 760 mmHg | |
| 中文名称: |
| |
| 英文名称: |
|
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||||||||||||||||||||||||||||||||||||
| N891396 | MACKLIN | N-(4-甲氧基苄基)-1-(萘-1-基)甲胺 | 97% | 303元/100mg; 606元/250mg; | 咨询 | ||||||||||||||||||||||||||||||||||||
储存：2-8°C,避光，保存于惰性气体中 | |||||||||||||||||||||||||||||||||||||||||
| 422689 | Sigma-Aldrich | Kir2.1 Inhibitor, ML133-CAS 185669-79-8-Calbiochem | The Kir2.1 Inhibitor, ML133, also referenced under CAS 185669-79-8, controls the biological activity of Kir2.1. This small molecule/inhibitor is primarily used for Cancer applica | 1954.93元/5 MG; | 咨询 | ||||||||||||||||||||||||||||||||||||
产品说明 一般描述 A cell-permeable, renal outer medullary potassium (ROMK) blocker that is shown to inhibit inward rectifier potassium channel, Kir2.1 (IC50 = 1.8 µM and 290 nM, at pH 7.4 and pH 8.5, respectively). It exhibits little selectivity against other members of the Kir2.x family, but has no effect on Kir1.1 (IC50 >300 µM) and displays weak activity for Kir4.1 and Kir7.1 (IC50 = 76 µM and 33 µM, respectively). It is reported to be assayed in 218 MLPCN HTS campaigns, demonstrating activity in only two assays that are not based on Kir2.1. Furthermore, it displays a relatively clean profile in a radioligand binding panel of 68 GPCRs, ion channels and transporters. 包装 5 mg in Glass bottle 警告 Toxicity: Standard Handling (A) 重悬 Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C. 其他说明 Lindsley, C.W., et al. 2011. ACS Chem. Biol.6, 845. 法律信息 CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||
| 314298 | Fluorochem | (4-methoxybenzyl)(1-naphthylmethyl)amine | 95% | 902元/1g; 2662元/5g; 7920元/25g; | 咨询 | ||||||||||||||||||||||||||||||||||||
基本信息
| |||||||||||||||||||||||||||||||||||||||||
m.cnreagent.com